| Date | Title | Description | Source |
| 16.04.2024 | The Nomination Committee's proposal for the election of Boar... | The Nomination Committee's proposal for the election of Board members and Chairperson of the Board i... | news.cisio... |
| 09.04.2024 | Global capability centres in India see hiring dip amid weste... | The hiring by global capability centres (GCCs) in India has slowed down in the year to March, accord... | business-s... |
| 23.03.2024 | Electoral bonds data: Metal, mining giants focus on home gro... | Two of India’s large metal mining conglomerates, Aditya Birla Group and Vedanta, directed a signific... | business-s... |
| 22.03.2024 | Novartis eyes sale of listed unit in India, says Global CEO ... | Novartis, the Swiss pharmaceutical giant, is considering selling its listed unit in India, Novartis ... | business-s... |
| 21.03.2024 | Advances in Digitalization Presented at the 10th Annual Gene... | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system... | prweb.com/... |
| 18.03.2024 | Everest Medicines Strengthens Management Team with Appointme... | SHANGHAI, March 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or t... | en.prnasia... |
| 15.03.2024 | Novartis expands its biopharmaceutical manufacturing site in... | Invests US$256 million to expand biopharmaceutical manufacturing facility in Singapore, addressing t... | en.prnasia... |
| 13.03.2024 | Chronic Myeloid Leukemia Treatment Market On A Growth Trajec... | - | globenewsw... |
| 13.03.2024 | The Rise of Patient-Centric Healthcare App Market: Booms Fut... | By technology, it is segmented into phone-based apps, web-based apps, and wearable patient centric a... | einpresswi... |
| 13.03.2024 | Top 7 Markets In Pharmaceuticals Industry – By The Business ... | - | globenewsw... |
| 13.03.2024 | Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Targ... | - | globenewsw... |
| 13.03.2024 | Global Oncologists Market Report 2024: Precision Medicine an... | - | globenewsw... |
| 13.03.2024 | Europe Pharmaceutical Suspension Market Report By Type, By D... | - | globenewsw... |
| 13.03.2024 | После вмешательства генпрокурора РФ 68 южноуральцев обеспече... | - | kommersant... |
| 12.03.2024 | Global Retinoblastoma Treatment Market Set to Reach $4.20 Bi... | - | globenewsw... |
| 12.03.2024 | Drug Discovery Market Size, Share And Growth Analysis For 20... | Drug Discovery Global Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
The Business ... | einpresswi... |
| 11.03.2024 | APPIS 2024: Healthcare Stakeholders Come Together to Priorit... | Since 2021, the APPIS platform has brought together over 2,000 people from more than 65 countries to... | en.prnasia... |
| 11.03.2024 | Cell Therapy Market Insights Report: Collaboration and Licen... | - | globenewsw... |
| 11.03.2024 | Olema Oncology Reports Fourth Quarter and Full-Year 2023 Fin... | Presented compelling clinical results for palazestrant both as a monotherapy and in combination with... | einpresswi... |
| 11.03.2024 | Contract Research And Manufacturing Services (CRAMS) Market ... | Contract Research And Manufacturing Services (CRAMS) Global Market Report 2024 – Market Size, Trends... | einpresswi... |
| 11.03.2024 | Regenerative Medicine Industry Analysis and Outlook 2024-203... | - | globenewsw... |
| 11.03.2024 | North America Pharmaceutical Suspension Market to 2030 | - | globenewsw... |
| 10.03.2024 | Blockbuster BeiGene Cancer Drug Adds Another FDA Approval | A BeiGene drug already used to treat several types of blood cancer now has an additional FDA approva... | medcitynew... |
| 08.03.2024 | Pediatric Clinical Trials Market Poised for Growth Amid Inno... | - | globenewsw... |
| 08.03.2024 | Joint Venture Deals in Pharmaceuticals and Biotechnology 201... | - | globenewsw... |
| 08.03.2024 | Global Dilated Cardiomyopathy Market Report 2024, Analysis a... | - | globenewsw... |
| 08.03.2024 | Psychedelic Drugs Market Size, Share And Growth Analysis For... | Psychedelic Drugs Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The... | einpresswi... |
| 08.03.2024 | CAR T-Cell Therapy Market Set for Healthy Growth after COVID... | CHICAGO, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- Astute Analytica, a leading provider of ... | einpresswi... |
| 08.03.2024 | Collaboration Deals in Pharmaceuticals Through 2019-2024 Fea... | - | globenewsw... |
| 08.03.2024 | Global Synthetic Hormones Market Projected to Reach $38.08 B... | - | globenewsw... |
| 08.03.2024 | Peptide Therapeutics Market Size, Share, Revenue, Trends And... | Peptide Therapeutics Market Report 2024 – Market Size, Trends, And Forecast 2024-2033
The Business R... | einpresswi... |
| 07.03.2024 | Pancreatic Cancer Drugs Global Market Report 2024 | - | globenewsw... |
| 07.03.2024 | Analysis of Co-promotion and Co-marketing Deals in Pharmaceu... | - | globenewsw... |
| 06.03.2024 | Myeloproliferative Disorders Drugs Market Report 2024-2033: ... | - | globenewsw... |
| 05.03.2024 | Novartis shareholders approve all resolutions proposed by th... | - | globenewsw... |
| 05.03.2024 | Biotechnology Licensing Deals Analysis Reveals Key Trends an... | - | globenewsw... |
| 05.03.2024 | Interleukin-2 (IL-2) Inhibitor Drug Pipeline Research Report... | - | globenewsw... |
| 05.03.2024 | FDA Approves Sandoz Biosimilars for Two Blockbuster Amgen Bo... | A blockbuster Amgen antibody that treats bone conditions is set to face its first biosimilar competi... | medcitynew... |
| 05.03.2024 | Global Transdermal Patches Market Report 2023-2029: Opportun... | - | globenewsw... |
| 04.03.2024 | Analgesics Market Set to Surge USD 50.7 Bn by 2028 | 6.6% CA... | Analgesics Market 2024
PORTLAND, OREGON, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- What is ... | einpresswi... |
| 04.03.2024 | Pharmaceutical Manufacturing Market Projected to Grow at 7.8... | Vantage Market Research
Pharmaceutical Manufacturing Market Size, Share, Industry Trends, Growth, an... | einpresswi... |
| 04.03.2024 | Growth Trajectory Of Merkel Cell Carcinoma Treatment Market:... | Exclusive Offer By The Business Research Company - Get 33% Discount On Opportunities And Strategies ... | einpresswi... |
| 31.01.2024 | Pfizer’s reset year starts with a little profit | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 18.01.2024 | Bayer’s Cost-Cutting Plans Take Aim at Multiple Layers of Ma... | Bayer is implementing a corporate restructuring that will slash an unspecified number of jobs, parti... | medcitynew... |
| 08.01.2024 | Novartis pays $250m upfront to acquire Calypso Biotech | | startuptic... |
| 05.01.2024 | Novartis expands production of Pluvicto™ with addition of it... | FDA approval of the company’s second US Radioligand Therapy (RLT) manufacturing facility increases R... | einpresswi... |
| 08.12.2023 | Latest Novartis Kisqali® NATALEE analysis reinforces 25% red... | With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali® (ribociclib)... | einpresswi... |
| 06.12.2023 | Why Cerevel Therapeutics has risen 50% in three days without... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 27.11.2023 | Novartis Issues Voluntary US Nationwide Recall of Two Lots o... | Summary
Company Announcement Date: November 24, 2023 FDA Publish Date: November 27, 2023 Product Typ... | einpresswi... |
| 13.11.2023 | Novartis to Pay Legend Biotech $100M in Pact Bringing Cell T... | Novartis aims to overcome two hurdles facing current cancer cell therapies: the lengthy time it take... | medcitynew... |
| 30.10.2023 | Your Monday morning biotech news roundup | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 13.10.2023 | ノバルティス、「前眼部」向け眼科用剤の資産売却を完了... | この資料は、ノバルティス（スイス・バーゼル）が2023年9月29日（現地時間）に発表したものを日本語に翻訳（要約）したもので、参考資料として提供するものです。資料の内容および解釈については、英語が優先... | prtimes.jp... |
| 11.10.2023 | ノバルティス、サンドの分離を実施し、イノベーティブ メディスンにフォーカスした企業への戦略的な転換を完了... | この資料は、ノバルティス（スイス・バーゼル）が2023年10月4日（現地時間）に発表したものを日本語に翻訳（要約）したもので、参考資料として提供するものです。資料の内容および解釈については、英語が優先... | prtimes.jp... |
| 03.10.2023 | Eli Lilly Jumps Into Radiopharmaceuticals via $1.4B Point Bi... | Eli Lilly’s scope in cancer is expanding to radiopharmaceuticals with the $1.4 billion acquisition o... | medcitynew... |
| 12.09.2023 | Four Swiss startups enter the DayOne Health 4.0 Accelerator | | startuptic... |
| 15.08.2023 | Pfizer Expands to Multiple Myeloma With FDA Approval for New... | Pfizer’s portfolio of medicines is expanding to multiple myeloma with FDA approval of a new drug tha... | medcitynew... |
| 25.07.2023 | Rigorous Data Are Key to Convince Payers, Investors in the W... | The most common and easiest way to take medicine is by swallowing a pill. For a new class of therapi... | medcitynew... |
| 20.07.2023 | Majic WMJI Morning Show Host Mark Nolan to Emcee Melanoma Re... | Register today for the Miles for Melanoma Cleveland 5k!
CLEVELAND (PRWEB) July 20, 2023
The Melanoma... | prweb.com/... |
| 18.07.2023 | Novartis Acquires DTx Pharma, for Approx. USD1 Billion | Novartis acquired DTx Pharma, a San Diego, CA-based biotechnology company, for approx. $1 Billion.
N... | finsmes.co... |
| 12.07.2023 | Sickle cell cures are coming. African children can’t be left... | The treatment of sickle cell disease is on the cusp of a historic breakthrough, with makers of two g... | statnews.c... |
| 08.06.2023 | Letter of Support (LOS) Initiative | Critical Path Institute's (C-Path) Predictive Safety Testing Consortium (PSTC), Nephrotoxicity Worki... | einpresswi... |
| 06.06.2023 | RxLightning Secures $17.5M to Streamline Specialty Medicatio... | Julia Regan, CEO and founder at RxLightning
What You Should Know:
RxLightning, creator of the indust... | hitconsult... |
| 06.06.2023 | RxLightening Secures $17.5M to Streamline Specialty Medicati... | What You Should Know:
RxLightning, creator of the industry’s first comprehensive platform for stream... | hitconsult... |
| 05.06.2023 | Потенциал искусственного интеллекта в пищевой промышленности... | По сравнению с развитыми странами, уровень внедрения ИИ в промышленности в России остается невысоким... | habr.com/r... |
| 09.05.2023 | How Baxter’s $4B Sale of Biopharma Biz Fits With Broader Lif... | Baxter International, a global healthcare products company with more than $15 billion in annual reve... | medcitynew... |
| 20.04.2023 | Cancer Biotech Abdera Reveals $142M for Better Antibody-Base... | Less than three years ago, a group of Canadian scientists got together to brainstorm a better radiop... | medcitynew... |
| 05.04.2023 | Advice From Tealium Customers on How to Implement a CDP | Knowing how to implement a CDP is easier than you may think! During Digital Velocity ‘22 we asked so... | martechcub... |
| 24.03.2023 | 23andMe, Novartis Launches Pilot for Lipoprotein(a) Educatio... | What You Should Know:
– In support of Lipoprotein(a) Awareness Day, 23andMe, a human genetics and bi... | hitconsult... |
| 20.03.2023 | Novartis shares Zolgensma long-term data demonstrating susta... | Children in LT-001 treated after SMA symptom onset maintained or achieved additional milestones up t... | einpresswi... |
| 19.03.2023 | Novartis shares Zolgensma long-term data demonstrating susta... | Children in LT-001 treated after SMA symptom onset maintained or achieved additional milestones up t... | einpresswi... |
| 16.03.2023 | Novartis Tafinlar + Mekinist approved by FDA for pediatric p... | New approval based on TADPOLE trial showing overall response rate (ORR) of 47% and median progressio... | einpresswi... |
| 20.02.2023 | Novartis announces the appointment of the Chairman-Designate... | Gilbert Ghostine, CEO of the Swiss multi-national fragrances business Firmenich appointed Chairman-D... | einpresswi... |
| 14.02.2023 | Doing More with Moore: Biotech’s Tech Moment | Eroom’s Law (the backwards Moore) is the often cited, and arguably inaccurate, observation that drug... | a16z.com/2... |
| 07.02.2023 | Novartis Highlights ESG and Business Performance as a Focuse... | NORTHAMPTON, MA / ACCESSWIRE / February 7, 2023 / Novartis is a focused medicines company with a pur... | accesswire... |
| 04.02.2023 | Patients with hidradenitis suppurativa experienced sustained... | In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secuki... | einpresswi... |
| 25.01.2023 | SEF.WomenAward: Die Finalistinnen stehen fest | | startuptic... |
| 24.01.2023 | Sandoz announces agreement to acquire leading antifungal age... | Sandoz plans to acquire worldwide product rights for Mycamine® (micafungin sodium) from Astellas Acq... | einpresswi... |
| 16.01.2023 | Novartis' CEO is charging ahead in cutting tens of thousands... | Vasant Narasimhan, the CEO of Novartis. Novartis This story is available exclusively to Insider subs... | businessin... |
| 11.01.2023 | STALICLA signs exclusive in-licensing agreement with Novarti... | | startuptic... |
| 27.10.2022 | The Max Foundation Announces Multi-Stakeholder Collaboration... | “We are humbled by the opportunity to address the leading cause of cancer deaths among women globall... | prweb.com/... |
| 26.10.2022 | Biotech’s newest odd couple: A pharma insider and a music ma... | D.A. Wallach’s first meeting with his business partner could have been the setting of a romantic com... | statnews.c... |
| 25.10.2022 | Novartis maintains growth momentum and confirms FY’22 Group ... | Ad hoc announcement pursuant to Art. 53 LR
Q3 sales grew +4% cc1 (-4% USD)
Innovative Medicines (IM)... | globenewsw... |
| 25.10.2022 | Novartis tosses more US PD-1 submission plans and anot... | Buried in Novartis’ third quarter report were a few key indication drops.
First, Novartis i... | endpts.com... |
| 24.10.2022 | Novartis investigational oral monotherapy iptacopan demonstr... | Ad hoc announcement pursuant to Art. 53 LR Phase III APPLY-PNH trial met its two primary endpoints f... | einpresswi... |
| 24.10.2022 | Novartis investigational oral monotherapy iptacopan demonstr... | Ad hoc announcement pursuant to Art. 53 LR
Phase III APPLY-PNH trial met its two primary endpoints f... | globenewsw... |
| 14.10.2022 | Novartis receives positive CHMP opinion for Pluvicto® for pa... | Phase III VISION trial showed Pluvicto® plus best standard of care significantly improved survival f... | globenewsw... |
| 23.09.2022 | Market share isn’t the only metric for biosimilars’ success... | Market share is often held up as the most relevant metric for the success of a biosimilar class. I b... | statnews.c... |
| 22.09.2022 | Why you need a data champion to score AI wins | Were you unable to attend Transform 2022? Check out all of the summit sessions in our on-demand libr... | venturebea... |
| 22.09.2022 | Novartis unveils new focused strategy, underpinned by eight ... | Transformation to pure-play Innovative Medicines company nears completion
Focusing strategy on five ... | globenewsw... |
| 19.09.2022 | Sandoz announces further progress on its biosimilar pipeline... | ROSALIA study met primary endpoints, confirming proposed biosimilar denosumab matches reference prod... | globenewsw... |
| 15.09.2022 | Novartis statement regarding competition authority investiga... | Company confident to clarify legitimacy of its position and fully cooperating with authorities
Basel... | globenewsw... |
| 10.09.2022 | Novartis Cosentyx® shows clinically meaningful symptom impro... | Results from two parallel trials show Cosentyx® (secukinumab) demonstrated superior efficacy vs plac... | globenewsw... |
| 09.09.2022 | Novartis Kisqali® adds one more year of survival benefit for... | New large pooled exploratory analysis from MONALEESA-2, -3 and -7 reinforces unparalleled overall su... | globenewsw... |
| 02.09.2022 | Novartis highlights depth of immunology pipeline with novel ... | Pivotal results for efficacy and safety of Cosentyx® (secukinumab) in hidradenitis suppurativa from ... | globenewsw... |
| 01.09.2022 | Novartis appoints Fiona Marshall, Ph.D., President of the No... | After seven years as President of NIBR and a member of the ECN, Dr. Bradner will pursue a next chapt... | globenewsw... |
| 30.08.2022 | Novartis presents new data in breast and prostate cancer at ... | Overall survival results from pooled exploratory analysis of MONALEESA trials in patients with aggre... | globenewsw... |
| 25.08.2022 | Novartis Is Spinning Off Its Generics Unit, Joining Pack of ... | The European pharmaceutical company Novartis is cutting loose its generics division, making it the l... | barrons.co... |
| 25.08.2022 | Novartis announces intention to separate Sandoz business to ... | Ad hoc announcement pursuant to Art. 53 LR Sandoz strategic review concludes that a separation of Sa... | globenewsw... |
| 15.08.2022 | Novartis provides update on Phase III CANOPY-A study evaluat... | Phase III CANOPY-A trial did not meet primary endpoint of disease-free survival in patients with sta... | globenewsw... |
| 11.08.2022 | FDA converts Novartis' NSCLC drug to a full approval wit... | Although Novartis discontinued its research into the use of Tabrecta in solid tumors, the... | endpts.com... |
